Jefferies Financial Group Issues Positive Forecast for Pediatrix Medical Group (NYSE:MD) Stock Price

Pediatrix Medical Group (NYSE:MD - Get Free Report) had its target price hoisted by investment analysts at Jefferies Financial Group from $14.00 to $18.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a "buy" rating on the stock. Jefferies Financial Group's price target points to a potential upside of 17.19% from the company's current price.

Other analysts have also issued research reports about the stock. Mizuho raised their price target on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a "neutral" rating in a research report on Monday. Truist Financial upped their target price on shares of Pediatrix Medical Group from $13.00 to $16.00 and gave the company a "hold" rating in a research report on Monday. UBS Group upped their target price on shares of Pediatrix Medical Group from $9.00 to $10.50 and gave the stock a "neutral" rating in a research note on Friday, August 9th. StockNews.com upgraded shares of Pediatrix Medical Group from a "sell" rating to a "hold" rating in a research note on Wednesday, August 7th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the company a "hold" rating in a report on Monday. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $16.10.

Pediatrix Medical Group Stock Performance

Shares of NYSE:MD traded up $0.22 during midday trading on Tuesday, reaching $15.36. 966,939 shares of the company's stock traded hands, compared to its average volume of 873,364. The company has a market cap of $1.32 billion, a price-to-earnings ratio of -5.05, a P/E/G ratio of 2.36 and a beta of 1.55. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.38 and a current ratio of 1.58. The stock has a 50 day moving average of $11.70 and a 200 day moving average of $9.45. Pediatrix Medical Group has a one year low of $6.62 and a one year high of $15.52.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings data on Friday, November 1st. The company reported $0.44 earnings per share for the quarter, beating analysts' consensus estimates of $0.37 by $0.07. Pediatrix Medical Group had a positive return on equity of 12.79% and a negative net margin of 12.65%. The firm had revenue of $511.20 million during the quarter, compared to analyst estimates of $498.87 million. During the same quarter last year, the business posted $0.29 earnings per share. The business's quarterly revenue was up .9% compared to the same quarter last year. As a group, equities research analysts anticipate that Pediatrix Medical Group will post 1.19 EPS for the current fiscal year.

Insider Transactions at Pediatrix Medical Group

In related news, CFO C Marc Richards sold 32,562 shares of the stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $10.08, for a total value of $328,224.96. Following the completion of the sale, the chief financial officer now directly owns 192,785 shares of the company's stock, valued at approximately $1,943,272.80. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, Director Laura A. Linynsky sold 7,000 shares of Pediatrix Medical Group stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $11.16, for a total value of $78,120.00. Following the completion of the transaction, the director now owns 30,805 shares in the company, valued at approximately $343,783.80. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO C Marc Richards sold 32,562 shares of the business's stock in a transaction on Friday, August 9th. The stock was sold at an average price of $10.08, for a total value of $328,224.96. Following the sale, the chief financial officer now owns 192,785 shares of the company's stock, valued at approximately $1,943,272.80. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 68,100 shares of company stock valued at $701,889 over the last three months. Company insiders own 1.20% of the company's stock.

Institutional Investors Weigh In On Pediatrix Medical Group

Several large investors have recently bought and sold shares of MD. Aristeia Capital L.L.C. acquired a new stake in Pediatrix Medical Group in the second quarter valued at $687,000. Vanguard Group Inc. grew its stake in Pediatrix Medical Group by 1.6% during the first quarter. Vanguard Group Inc. now owns 10,557,572 shares of the company's stock worth $105,892,000 after buying an additional 164,333 shares in the last quarter. Boston Partners increased its stake in Pediatrix Medical Group by 34.0% in the first quarter. Boston Partners now owns 1,786,434 shares of the company's stock valued at $17,702,000 after acquiring an additional 453,254 shares during the last quarter. Rubric Capital Management LP increased its stake in shares of Pediatrix Medical Group by 797.0% in the 2nd quarter. Rubric Capital Management LP now owns 8,150,000 shares of the company's stock valued at $61,532,000 after purchasing an additional 7,241,400 shares during the last quarter. Finally, ClariVest Asset Management LLC acquired a new position in Pediatrix Medical Group during the second quarter worth about $1,721,000. Institutional investors own 97.71% of the company's stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.